A Whole Cell Metal-Organic Framework Encapsulated Vaccine Against Septicemic UPEC Infection
Luzuriaga, M. A.; Herbert, F. C.; Brohlin, O.; Shahrivarkevishahi, A.; Wijesundara, Y. H.; Veera, K.; Benjamin, C. E.; Popal, S.; Burton, M. D.; Ingersoll, M. A.; De Nisco, N. J.; Gassensmith, J. J.
Show abstract
The increasing rate of resistance of bacterial infection against antibiotics requires next generation approaches to fight potential pandemic spread. The development of vaccines against pathogenic bacteria has been difficult owing, in part, to the genetic diversity of bacteria. Hence, there are many potential target antigens and little a priori knowledge of which antigen/s will elicit protective immunity. The painstaking process of selecting appropriate antigens could be avoided with whole-cell bacteria; however, whole-cell formulations typically fail to produce long-term and durable immune responses. These complications are one reason why no vaccine against any type of pathogenic E. coli has been successfully clinically translated. As a proof of principle, we demonstrate a method to enhance the immunogenicity of a model pathogenic E. coli strain by forming a slow releasing depot. The E. coli strain CFT073 was biomimetically mineralized within a metal-organic framework (MOF). This process encapsulates the bacteria within 30 minutes in water and at ambient temperatures. Vaccination with this new formulation substantially enhances antibody production and results in significantly enhanced survival in a mouse model of bacteremia compared to standard inactivated formulations.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Heterologous Prime-Boost with Immunologically Orthogonal Protein Nanoparticles for Peptide Immunofocusing 96%
- Immunofilaments Provide a Nanoscale Platform for In Vivo T Cell Expansion and Cancer Immunotherapy 95%
- SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity Through B Cell Antigen Presentation 95%
Similar papers in this journal
- TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccination 96%
- Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine 96%
- A novel microporous biomaterial vaccine platform for long-lasting antibody mediated immunity against viral infection. 95%
Similar papers in this journal
- A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses 96%
- Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine 95%
- Dextran-based T-cell expansion nanoparticles for manufacturing CAR T cells with augmented efficacy 94%
Similar papers in this journal
- Hydrogel-based slow release of a receptor-binding domain subunit vaccine elicits neutralizing antibody responses against SARS-CoV-2 96%
- Inhalable Polymeric Nanoparticle Vaccine for Lysosome-targeting Co-delivery of Antigen and Adjuvant with Enhanced Immunoprotection 95%
- Nanoscale biodegradable printing for designed tuneability of vaccine delivery kinetics 94%
Similar papers in this journal
- Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative 94%
- SaccuFlow: High-throughput Analysis Platform to Investigate Bacterial Cell Wall Interactions 92%
- An engineered prodrug selectively suppresses β-lactam resistant bacteria in a mixed microbial setting 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.